Literature DB >> 15875944

[Concentration and protein composition of circulating immune complexes in the blood of patients with schizophrenia and subjects with positive familial history of disease].

K R Mailian, A S Boiadzhian, A F Sogoian, R B Sim, L A Manukian.   

Abstract

A comparative study of blood serum concentrations and pathogenic properties of circulating immune complexes (CIC), along with identification of their protein composition, was conducted in 45 patients with schizophrenia, 15 their healthy relatives and 39 normal controls. In patients and their relatives, mean concentration of small CIC was within the normal range, while concentrations of giant, large and middle CIC were higher than those of the controls (p<0.001). Over 80% of schizophrenic patients and their relatives had pathogenic immune complexes in the circulation. Clinical and immunologic analysis of patients with schizophrenia revealed a correlation between the illness duration and CIC concentration for all sizes. Smokers had significantly lower levels of small CIC comparing to non-smokers. Determination of CIC composition in patients and relatives revealed a presence of specific proteins in the immune complexes with molecular weights of 36 and 25 kDa. The results suggest genetic determination of autoimmune processes in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15875944

Source DB:  PubMed          Journal:  Zh Nevrol Psikhiatr Im S S Korsakova        ISSN: 1997-7298


  7 in total

1.  Association of C1QB gene polymorphism with schizophrenia in Armenian population.

Authors:  Roksana Zakharyan; Aren Khoyetsyan; Arsen Arakelyan; Anna Boyajyan; Anaida Gevorgyan; Anna Stahelova; Frantisek Mrazek; Martin Petrek
Journal:  BMC Med Genet       Date:  2011-09-28       Impact factor: 2.103

Review 2.  The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders.

Authors:  Emily G Severance; Dag Tveiten; Lief H Lindström; Robert H Yolken; Karl L Reichelt
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

3.  Complement C1q formation of immune complexes with milk caseins and wheat glutens in schizophrenia.

Authors:  Emily G Severance; Kristin L Gressitt; Meredith Halling; Cassie R Stallings; Andrea E Origoni; Crystal Vaughan; Sunil Khushalani; Armin Alaedini; Didier Dupont; Faith B Dickerson; Robert H Yolken
Journal:  Neurobiol Dis       Date:  2012-07-16       Impact factor: 5.996

Review 4.  Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling.

Authors:  Emily G Severance; Robert H Yolken; William W Eaton
Journal:  Schizophr Res       Date:  2014-07-15       Impact factor: 4.939

5.  Maternal complement C1q and increased odds for psychosis in adult offspring.

Authors:  Emily G Severance; Kristin L Gressitt; Stephen L Buka; Tyrone D Cannon; Robert H Yolken
Journal:  Schizophr Res       Date:  2014-09-04       Impact factor: 4.939

6.  Schizophrenia Plasma Autoantibodies Promote 'Biased Agonism' at the 5-Hydroxytryptamine 2A Receptor: Neurotoxicity is Positively Modulated by Metabotropic Glutamate 2/3 Receptor Agonism.

Authors:  Mark B Zimering; Shree G Nadkarni
Journal:  Endocrinol Diabetes Metab J       Date:  2019-08-14

7.  Role of Immune and Autoimmune Dysfunction in Schizophrenia.

Authors:  Emily G Severance; Robert H Yolken
Journal:  Handb Behav Neurosci       Date:  2015-11-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.